Literature DB >> 12003803

Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice.

Gembu Imamura1, Alberto A Bertelli, Aldo Bertelli, Hajime Otani, Nilanjana Maulik, Dipak K Das.   

Abstract

Resveratrol, a natural antioxidant and polyphenol found in grapes and wine, has been found to pharmacologically precondition the heart through the upregulation of nitric oxide (NO). To gain further insight of the role of NO in resveratrol preconditioning, mouse hearts devoid of any copies of inhibitory NO synthase (iNOS) (iNOS knockout) and corresponding wild-type hearts were perfused with 10 microM resveratrol for 15 min followed by 25 min of ischemia and 2 h of reperfusion. Control experiments were performed with wild-type and iNOS knockout hearts that were not treated with resveratrol. Resveratrol-treated wild-type mouse hearts displayed significant improvement in postischemic ventricular functional recovery compared with those of nontreated hearts. Both resveratrol-treated and nontreated iNOS knockout mouse hearts resulted in relatively poor recovery in ventricular function compared with wild-type resveratrol-treated hearts. Myocardial infarct size was lower in the resveratrol-treated wild-type mouse hearts compared with other group of hearts. In concert, a number of apoptotic cardiomyocytes was lower in the wild-type mouse hearts treated with resveratrol. Cardioprotective effects of resveratrol was abolished when the wild-type mouse hearts were simultaneously perfused with aminoguanidine, an iNOS inhibitor. Resveratrol induced the expression of iNOS in the wild-type mouse hearts, but not in the iNOS knockout hearts, after only 30 min of reperfusion. Expression of iNOS remained high even after 2 h of reperfusion. Resveratrol-treated wild-type mouse hearts were subjected to a lower amount of oxidative stress as evidenced by reduced amount of malonaldehyde content in these hearts compared with iNOS knockout and untreated hearts. The results of this study demonstrated that resveratrol was unable to precondition iNOS knockout mouse hearts, whereas it could successfully precondition the wild-type mouse hearts, indicating an essential role of iNOS in resveratrol preconditioning of the heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12003803     DOI: 10.1152/ajpheart.01013.2001

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Effect of modest alcohol consumption over 1-2 weeks on the coronary microcirculation of normal subjects.

Authors:  Sanjiv Kaul; Todd Belcik; Saul Kalvaitis; Ananda R Jayaweera; Si-Wan Choi; Kevin Wei
Journal:  Eur J Echocardiogr       Date:  2010-04-08

Review 2.  Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis.

Authors:  Haim Shapiro; Pierre Singer; Zamir Halpern; Rafael Bruck
Journal:  Gut       Date:  2006-08-24       Impact factor: 23.059

3.  Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury.

Authors:  Shimin Liu; Gehua Zhen; Rung-Chi Li; Sylvain Doré
Journal:  J Exp Stroke Transl Med       Date:  2013-02-02

Review 4.  Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Authors:  Belma Turan; Erkan Tuncay; Guy Vassort
Journal:  J Bioenerg Biomembr       Date:  2012-04       Impact factor: 2.945

5.  Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat.

Authors:  Suresh Varma Penumathsa; Mahesh Thirunavukkarasu; Srikanth Koneru; Bela Juhasz; Lijun Zhan; Rima Pant; Venugopal P Menon; Hajime Otani; Nilanjana Maulik
Journal:  J Mol Cell Cardiol       Date:  2006-12-26       Impact factor: 5.000

Review 6.  Resveratrol and red wine, healthy heart and longevity.

Authors:  Dipak K Das; Subhendu Mukherjee; Diptarka Ray
Journal:  Heart Fail Rev       Date:  2010-09       Impact factor: 4.214

7.  Sulfaphenazole protects heart against ischemia-reperfusion injury and cardiac dysfunction by overexpression of iNOS, leading to enhancement of nitric oxide bioavailability and tissue oxygenation.

Authors:  Mahmood Khan; Iyyapu K Mohan; Vijay K Kutala; Sainath R Kotha; Narasimham L Parinandi; Robert L Hamlin; Periannan Kuppusamy
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

8.  Deficiency of iNOS Does Not Prevent Isoproterenol-induced Cardiac Hypertrophy in Mice.

Authors:  Hye-Na Cha; Geu-Ru Hong; Yong-Woon Kim; Jong-Yeon Kim; Jin-Myoung Dan; So-Young Park
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

9.  Resveratrol protects the ovary against chromium-toxicity by enhancing endogenous antioxidant enzymes and inhibiting metabolic clearance of estradiol.

Authors:  Sakhila K Banu; Jone A Stanley; Kirthiram K Sivakumar; Joe A Arosh; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2016-04-27       Impact factor: 4.219

10.  Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo.

Authors:  X-Y Zhao; G-Y Li; Y Liu; L-M Chai; J-X Chen; Y Zhang; Z-M Du; Y-J Lu; B-F Yang
Journal:  Br J Pharmacol       Date:  2008-03-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.